Sağlık Teknolojisi
Arjantin Şirketleri tek bir sektörde faaliyet göstermektedir:sağlık teknolojisi
Bu Arjantin Şirketleri aynı sektörde, sağlık teknolojisi, faaliyet göstermektedir. En fazla ayrıntıyı almanıza yardımcı olmak için fiyat, değişim ve diğer istatistiklerle donatılmıştır. Liste her stratejiye uygun hisse senetleri içerir: ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) gibi büyük sermayeli devler, LABORATORIOS RICHMOND SACIF gibi en çok kazananlar ve daha fazlası. Listeyi filtreleyin ve şirketlerin performansını uygun bir şekilde kontrol edin.
Sembol | Piyasa Değeri | Fiyat | Değişim % | Hacim | Bağ Hacim | FKO | EPS Seyreltilmiş TTM | EPS Seyreltilmiş Büyüme TTM YY | Tmt getirisi % TTM | Analist Değerlendirmesi |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)DR | 720,65 T ARS | 13,200 USD | −2,94% | 29 | 0,06 | 102,44 | 124,85 ARS | +178,70% | 0,34% | — |
| LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 720,65 T ARS | 15.575,000 ARS | +0,32% | 1,4 K | 0,20 | 124,75 | 124,85 ARS | +564,33% | 0,34% | — |
 JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD)DR | 370,29 T ARS | 10,000 USD | 0,00% | 174 | 0,14 | 31,57 | 306,92 ARS | +50,08% | 1,66% | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 370,29 T ARS | 1.250,000 ARS | 0,00% | 1 | 0,07 | — | — | — | — | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 370,29 T ARS | 11.775,000 ARS | +1,29% | 2,64 K | 0,03 | 38,37 | 306,92 ARS | +257,75% | 1,66% | — |
 ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD)DR | 317,12 T ARS | 17,150 USD | −4,46% | 43 | 0,69 | 7,09 | 2.343,37 ARS | +18,73% | 1,73% | — |
| ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 317,12 T ARS | 20.275,000 ARS | −0,86% | 153 | 0,12 | 8,65 | 2.343,37 ARS | +183,01% | 1,73% | — |
 MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD)DR | 259,1 T ARS | 20,400 USD | −3,77% | 5 | 0,10 | 22,38 | 883,37 ARS | +319,19% | 1,62% | — |
| MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 259,1 T ARS | 23.050,000 ARS | −1,18% | 183 | 0,09 | 26,09 | 883,37 ARS | +899,22% | 1,62% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 223,92 T ARS | 30.900,000 ARS | +2,32% | 7 | 0,02 | 55,28 | 558,94 ARS | +251,94% | 0,14% | — |
 ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORDDR | 220,8 T ARS | 8.050,000 ARS | −0,49% | 24 | 0,25 | 152,20 | 52,89 ARS | +386,62% | 0,00% | — |
 AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)DR | 215,79 T ARS | 33,800 USD | −1,74% | 14 | 0,52 | 48,32 | 677,80 ARS | +64,44% | 1,46% | — |
| AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 215,79 T ARS | 39.100,000 ARS | −1,45% | 21 | 0,02 | 57,69 | 677,80 ARS | +291,99% | 1,46% | — |
 ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD)DR | 205,88 T ARS | 28,450 USD | −3,23% | 19 | 0,68 | 43,76 | 629,98 ARS | +55,55% | 0,90% | — |
| ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1 DR | 205,88 T ARS | 34.450,000 ARS | +1,85% | 21 | 0,01 | 54,68 | 629,98 ARS | +270,79% | 0,90% | — |
 NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD)DR | 203,79 T ARS | 25,300 USD | −0,39% | 1 | 0,31 | 2,83 | 8.672,72 ARS | +140,89% | 3,70% | — |
| NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 203,79 T ARS | 30.000,000 ARS | +3,36% | 9 | 0,04 | 3,46 | 8.672,72 ARS | +474,20% | 3,70% | — |
 DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORDDR | 180,09 T ARS | 5.290,000 ARS | 0,00% | 55 | 0,16 | 71,72 | 73,76 ARS | +137,74% | 0,19% | — |
 PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD)DR | 155,9 T ARS | 6,800 USD | +1,04% | 1,24 K | 0,58 | 28,07 | 234,71 ARS | +35,96% | 3,12% | — |
| PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 155,9 T ARS | 7.940,000 ARS | +1,40% | 11,91 K | 0,42 | 33,83 | 234,71 ARS | +224,10% | 3,12% | — |
 AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)DR | 153 T ARS | 9,750 USD | −2,30% | 54 | 0,89 | 37,93 | 249,09 ARS | −50,42% | 2,28% | — |
| AMGNAMGEN INC CEDEAR EACH 30 REP 1 DR | 153 T ARS | 10.725,000 ARS | −0,69% | 230 | 0,05 | 43,06 | 249,09 ARS | +18,17% | 2,28% | — |
 GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD)DR | 119,72 T ARS | 24,300 USD | −3,19% | 3 | 0,27 | — | −50,65 ARS | −107,71% | 1,66% | — |
| GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001 DR | 119,72 T ARS | 27.300,000 ARS | −0,73% | 48 | 0,08 | — | −50,65 ARS | −118,38% | 1,66% | — |
 BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USDDR | 119,42 T ARS | 19,100 USD | +1,06% | 5 | 0,61 | — | −1.078,84 ARS | −253,68% | 2,01% | — |
| BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 119,42 T ARS | 22.975,000 ARS | +2,91% | 6 | 0,01 | — | −1.078,84 ARS | −466,33% | 2,01% | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 118,14 T ARS | 25.275,000 ARS | −3,90% | 14 | 0,01 | 37,58 | 672,48 ARS | +274,72% | 1,93% | — |
 GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD)DR | 71,24 T ARS | 8,150 USD | −4,12% | 93 | 1,58 | 25,65 | 307,84 ARS | −37,30% | 3,13% | — |
| GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 71,24 T ARS | 10.100,000 ARS | +1,71% | 105 | 0,17 | 32,81 | 307,84 ARS | +49,45% | 3,13% | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 25,76 T ARS | 6.200,000 ARS | +0,81% | 4 | 0,00 | — | −689,04 ARS | −3,81% | 0,00% | — |
 BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD)DR | 21,42 T ARS | 11,600 USD | −1,28% | 9 | 0,55 | 16,16 | 695,64 ARS | +96,62% | 0,00% | — |
| BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 21,42 T ARS | 13.200,000 ARS | +2,72% | 74 | 0,12 | 18,98 | 695,64 ARS | +368,68% | 0,00% | — |
 MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD)DR | 13,71 T ARS | 1,900 USD | 0,00% | 25 | 0,12 | — | −262,17 ARS | +31,39% | 0,00% | — |
| MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORD DR | 13,71 T ARS | 2.185,000 ARS | +2,82% | 2,54 K | 0,04 | — | −262,17 ARS | −63,54% | 0,00% | — |
 RICHLABORATORIOS RICHMOND SACIF | 143,74 B ARS | 1.790,000 ARS | +4,37% | 7,11 K | 0,45 | 18,59 | 96,29 ARS | — | 0,00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4,6 B ARS | 108,000 ARS | 0,00% | 400 | 0,09 | 25,30 | 4,27 ARS | +64,50% | 0,00% | — |